Closure of Trading Window for quarter ending 31st December, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eiko Lifesciences Ltd has informed the BSE that its trading window for dealing in company securities will remain closed for designated persons and their immediate relatives from Thursday, 01st January, 2026, until 48 hours after the upcoming Board Meeting. The Board Meeting will consider the Un-Audited Standalone and Consolidated Financial Results for the quarter ending 31st December, 2025 (Q3 FY26). The exact date of the Board Meeting will be communicated separately. The filing is made in compliance with SEBI's Insider Trading Regulations, 2015 and the company's internal Code of Conduct. The intimation was signed by Chintan Doshi, Company Secretary and Compliance Officer.
This is a routine regulatory compliance filing and is not material to the stock price by itself. However, it indicates that Q3 FY26 results are approaching, which may lead to earnings-related movement once the numbers are announced.